Immunovant, Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript November 10, 2025
Immunovant, Inc. misses on earnings expectations. Reported EPS is $-0.72851 EPS, expectations were $-0.72.
Operator: Thank you for standing by. Welcome to the Roivant Second Quarter 2025 Earnings Call. [Operator Instructions] Please note that today’s conference is being recorded. I will now hand the conference over to your first speaker, Stephanie Lee. You may begin.
Stephanie Lee Griffin: Good morning, and...
